Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
Saved in:
| Title: | Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis. |
|---|---|
| Authors: | Volpato M; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Perry SL; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Marston G; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Ingram N; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Cockbain AJ; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Burghel H; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Mann J; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Lowes D; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Wilson E; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Droop A; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.; MRC Medical Bioinformatics Centre, University of Leeds, Leeds, LS2 9NL, UK., Randerson-Moor J; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Coletta PL; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Hull MA; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom. |
| Source: | Oncotarget [Oncotarget] 2016 May 10; Vol. 7 (19), pp. 28139-50. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27058904 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Volpato+M%22">Volpato M</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Perry+SL%22">Perry SL</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Marston+G%22">Marston G</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ingram+N%22">Ingram N</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cockbain+AJ%22">Cockbain AJ</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burghel+H%22">Burghel H</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mann+J%22">Mann J</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lowes+D%22">Lowes D</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wilson+E%22">Wilson E</searchLink>; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Droop+A%22">Droop A</searchLink>; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.; MRC Medical Bioinformatics Centre, University of Leeds, Leeds, LS2 9NL, UK.<br /><searchLink fieldCode="AU" term="%22Randerson-Moor+J%22">Randerson-Moor J</searchLink>; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coletta+PL%22">Coletta PL</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hull+MA%22">Hull MA</searchLink>; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2016 May 10; Vol. 7 (19), pp. 28139-50. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27058904 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.18632/oncotarget.8579 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 28139 Titles: – TitleFull: Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Volpato M – PersonEntity: Name: NameFull: Perry SL – PersonEntity: Name: NameFull: Marston G – PersonEntity: Name: NameFull: Ingram N – PersonEntity: Name: NameFull: Cockbain AJ – PersonEntity: Name: NameFull: Burghel H – PersonEntity: Name: NameFull: Mann J – PersonEntity: Name: NameFull: Lowes D – PersonEntity: Name: NameFull: Wilson E – PersonEntity: Name: NameFull: Droop A – PersonEntity: Name: NameFull: Randerson-Moor J – PersonEntity: Name: NameFull: Coletta PL – PersonEntity: Name: NameFull: Hull MA IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 05 Text: 2016 May 10 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1949-2553 Numbering: – Type: volume Value: 7 – Type: issue Value: 19 Titles: – TitleFull: Oncotarget Type: main |
| ResultId | 1 |